The Central Epidemic Command Center (CECC) recently launched a website to recruit volunteers to participate in the clinical trials of the locally developed vaccines in order to speed up the production of domestic vaccines.
However, the government’s decision has attracted criticism from legislators, including Lin Shu-fen (林淑芬) and Chiang Wan-an (蔣萬安), who expressed concerns of eventual health complications.
Legislator Lin from the democratic progressive party questioned the director of the Food and Drug Administration, FDA (食藥署) on the topic Tuesday at the Legislative Yuan.
The Phase II clinical trial of the vaccine has not yet been approved by the “Institutional Review Board” (IRB, 人體試驗委員會), and according to the “Drug Injury Relief Act” (藥害救濟法), those injured using experimental drugs cannot apply for drug relief.
In this regard, she criticized the government for launching a registration platform recruiting volunteers despite the risks.
She queried Wu Shou-Mei (吳秀梅), the director of FDA, on who should be held responsible for any future incidents and adverse reactions that happened to the test subjects recruited by the government’s platform?
In response, Wu Shou-Mei said that the website is only for a “registration of intent” and there is “no guarantee regarding vaccine safety” for which the manufacturers will be held responsible for any future incidents.
Tensions ran high when Lin eventually asked the committee to pause the timing in order to grab some documents she prepared to which Director Wu Shou-mei retorted “ten minutes is already up,” which infuriated the ruling party’s legislator.
She lashed out at the arrogance of the officials saying: “How dare you ask legislators to get off stage just because their time is up?”